
|Articles|October 9, 2012
Novel antiviral research targets herpes simplex, herpes zoster
Promising developments in antiviral therapies include potential vaccines and treatments for herpes simplex and herpes zoster, said Stephen K. Tyring, M.D., Ph.D., at the 2012 Fall Clinical Dermatology Conference.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
3
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
4
Dermatology Conferences and Meetings Calendar: December 2025
5


















